Mette Kjær Killie

1.2k total citations
28 papers, 787 citations indexed

About

Mette Kjær Killie is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Mette Kjær Killie has authored 28 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 11 papers in Genetics and 4 papers in Immunology. Recurrent topics in Mette Kjær Killie's work include Platelet Disorders and Treatments (23 papers), Blood groups and transfusion (19 papers) and Blood disorders and treatments (11 papers). Mette Kjær Killie is often cited by papers focused on Platelet Disorders and Treatments (23 papers), Blood groups and transfusion (19 papers) and Blood disorders and treatments (11 papers). Mette Kjær Killie collaborates with scholars based in Norway, Sweden and United Kingdom. Mette Kjær Killie's co-authors include Bjøŕn Skogen, Anne Husebekk, Jens Kjeldsen‐Kragh, Ingrid Randen, Heidi Tiller, Maria Therese Ahlén, Pål Øian, Rolf Seljelid, Lill‐Tove Busund and Tor B. Stuge and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and American Journal of Obstetrics and Gynecology.

In The Last Decade

Mette Kjær Killie

27 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mette Kjær Killie Norway 14 599 259 170 120 109 28 787
Jean-Marie Saint-Remy Belgium 16 568 0.9× 38 0.1× 203 1.2× 156 1.3× 235 2.2× 46 993
PA Taylor United States 11 442 0.7× 65 0.3× 644 3.8× 82 0.7× 34 0.3× 14 870
BM Sandmaier United States 10 153 0.3× 48 0.2× 141 0.8× 87 0.7× 65 0.6× 18 384
A. M. Holburn United Kingdom 10 171 0.3× 80 0.3× 102 0.6× 77 0.6× 108 1.0× 32 321
LD Notarangelo Italy 13 137 0.2× 92 0.4× 254 1.5× 97 0.8× 8 0.1× 19 534
Edwin van Mirre Netherlands 6 89 0.1× 61 0.2× 252 1.5× 120 1.0× 221 2.0× 6 413
T Radaszkiewicz Austria 14 191 0.3× 42 0.2× 357 2.1× 88 0.7× 96 0.9× 27 643
CA Mullen United States 11 144 0.2× 201 0.8× 84 0.5× 129 1.1× 6 0.1× 13 489
R. Hintermeíer-Knabe Germany 6 314 0.5× 27 0.1× 319 1.9× 54 0.5× 51 0.5× 8 488
S Kreczko Pakistan 10 174 0.3× 41 0.2× 98 0.6× 113 0.9× 13 0.1× 16 423

Countries citing papers authored by Mette Kjær Killie

Since Specialization
Citations

This map shows the geographic impact of Mette Kjær Killie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mette Kjær Killie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mette Kjær Killie more than expected).

Fields of papers citing papers by Mette Kjær Killie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mette Kjær Killie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mette Kjær Killie. The network helps show where Mette Kjær Killie may publish in the future.

Co-authorship network of co-authors of Mette Kjær Killie

This figure shows the co-authorship network connecting the top 25 collaborators of Mette Kjær Killie. A scholar is included among the top collaborators of Mette Kjær Killie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mette Kjær Killie. Mette Kjær Killie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mörtberg, Anette, Stephan Meinke, Mette Kjær Killie, et al.. (2016). Sensitive detection of platelet-specific antibodies with a modified MAIPA using biotinylated antibodies and streptavidin-coated beads. Journal of Immunological Methods. 434. 9–15. 9 indexed citations
2.
Kapur, Rick, Carolien A. M. Koeleman, Remco Visser, et al.. (2013). A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy. Blood. 123(4). 471–480. 165 indexed citations
3.
Tiller, Heidi, Mette Kjær Killie, Anne Husebekk, Bjøŕn Skogen, & Jens Kjeldsen‐Kragh. (2013). 152: The natural course of HPA-1a-immunized subsequent pregnancies and clinical outcome of neonates. American Journal of Obstetrics and Gynecology. 210(1). S89–S89. 1 indexed citations
5.
Ahlén, Maria Therese, Anne Husebekk, Mette Kjær Killie, et al.. (2011). The Development of Severe Neonatal Alloimmune Thrombocytopenia due to Anti-HPA-1a Antibodies Is Correlated to MaternalABOGenotypes. SHILAP Revista de lepidopterología. 2012. 1–5. 13 indexed citations
6.
Tiller, Heidi, Mette Kjær Killie, Anne Husebekk, et al.. (2011). Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys. Acta Obstetricia Et Gynecologica Scandinavica. 91(1). 79–86. 44 indexed citations
7.
Skogen, Bjøŕn, Mette Kjær Killie, Jens Kjeldsen‐Kragh, et al.. (2010). Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and prevention. Expert Review of Hematology. 3(5). 559–566. 31 indexed citations
8.
Killie, Mette Kjær, et al.. (2010). Quantitative MAIPA: Comparison of different MAIPA protocols. Transfusion and Apheresis Science. 43(2). 149–154. 24 indexed citations
9.
Bessos, Hagop, Mette Kjær Killie, Jerard Seghatchian, Bjøŕn Skogen, & S. J. Urbaniak. (2009). The relationship of anti-HPA-1a amount to severity of neonatal alloimmune thrombocytopenia – Where does it stand?. Transfusion and Apheresis Science. 40(2). 75–78. 13 indexed citations
10.
Husebekk, Anne, Mette Kjær Killie, Jens Kjeldsen‐Kragh, & Bjøŕn Skogen. (2009). Is it time to implement HPA-1 screening in pregnancy?. Current Opinion in Hematology. 16(6). 497–502. 20 indexed citations
11.
Valentin, Nathalie, Katia Gagne, L. Hallé, et al.. (2007). The alloimmune response to the human platelet antigen‐1a is not related to maternal‐fetal killer immunoglobulinlike receptor/HLA‐Cw combinations. Transfusion. 47(12). 2322–2329. 1 indexed citations
12.
Killie, Mette Kjær, Anne Husebekk, Cécile Kaplan, Ellen Taaning, & Bjøŕn Skogen. (2006). Maternal human platelet antigen‐1a antibody level correlates with the platelet count in the newborns: a retrospective study. Transfusion. 47(1). 55–58. 34 indexed citations
13.
Lindemann, Rolf, et al.. (2004). Tre spesielle graviditetsforløp til ettertanke. Tidsskrift for Den Norske Laegeforening.
14.
Lindemann, Rolf, et al.. (2004). [Three special cases of pregnancy outcome to reflect about].. PubMed. 124(17). 2244–6. 1 indexed citations
15.
Killie, Mette Kjær, Jens Kjeldsen‐Kragh, Ingrid Randen, Bjøŕn Skogen, & Anne Husebekk. (2004). Evaluation of a new flow cytometric HPA 1a screening method. Transfusion and Apheresis Science. 30(2). 89–92. 22 indexed citations
16.
17.
Busund, Lill‐Tove, Mette Kjær Killie, Kristian Bartnes, & Rolf Seljelid. (2003). Spontaneously formed tumorigenic hybrids of Meth A sarcoma cells and macrophages in vivo. International Journal of Cancer. 106(2). 153–159. 28 indexed citations
18.
Busund, Lill‐Tove, Mette Kjær Killie, Kristian Bartnes, Randi Olsen, & Rolf Seljelid. (2002). Spontaneous hybridization of macrophages and Meth A sarcoma cells. International Journal of Cancer. 98(4). 573–581. 10 indexed citations
19.
Busund, Lill‐Tove, Mette Kjær Killie, Kristian Bartnes, & Rolf Seljelid. (2002). Spontaneously formed tumorigenic hybrids of Meth A sarcoma and macrophages grow faster and are better vascularized than the parental tumor. International Journal of Cancer. 100(4). 407–413. 22 indexed citations
20.
Gao, Qipin, Gøril Berntzen, Mette Kjær Killie, & Rolf Seljelid. (1997). Cytokine-Stimulating (In Vitro) Effect on Human Monocytes of Conjugates of Soluble Curdlan and Albumin Microbeads. Drug Delivery. 4(4). 239–245. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026